Titre:
  • Ulceration and stage are predictive of interferon efficacy in melanoma: results of the phase III adjuvant trials EORTC 18952 and EORTC 18991.
Auteur:Eggermont, A; Suciu, Stefan; Testori, Alessandro; Kruit, Wim H; Marsden, Jeremy; Punt, Cornelis; Santinami, M.; Sales, François; Schadendorf, Dirk; Patel, Poulam; Dummer, Reinhard; Robert, Caroline; Keilholz, Ulrich; Yver, Antoine; Spatz, Alain
Informations sur la publication:European journal of cancer, 48, 2, page (218-225)
Statut de publication:Publié, 2012-01
Sujet CREF:Cancérologie
MeSH keywords:Antineoplastic Agents -- therapeutic use
Chemotherapy, Adjuvant
Clinical Trials, Phase III as Topic
Disease-Free Survival
Epidemiologic Methods
Female
Humans
Immunologic Factors -- administration & dosage
Interferon-alpha -- administration & dosage
Male
Melanoma -- drug therapy -- mortality -- pathology
Neoplasm Staging
Polyethylene Glycols -- administration & dosage
Predictive Value of Tests
Randomized Controlled Trials as Topic
Recombinant Proteins -- administration & dosage
Skin Neoplasms -- drug therapy -- mortality -- pathology
Ulcer -- pathology
Note générale:Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0959-8049
info:doi/10.1016/j.ejca.2011.09.028
info:pii/S0959-8049(11)00787-8
info:scp/84655168007
info:pmid/22056637